| Market Cap | ₹153Cr |
| ROE | 18.49% |
| P/E Ratio(TTM) | 9.59 |
| EPS(TTM) | 9.16 |
| P/B Ratio | 1.49 |
| Dividend Yield | 0.00% |
| Industry P/E | 55.77 |
| Book Value | 59.02 |
| Debt to Equity | 0.19 |
| Face Value | 10 |
| Managing Director | Pawan Kumar |
| Founded | 2011 |
| BSE Symbol | 544482 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 45.36 | ||
| Metropolis Healthcare | NA (0.00%) | 60.70 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 65.31 | ||
| Thyrocare Technologies | NA (0.00%) | 47.73 |